Literature DB >> 19112718

[Transciptome among Mexicans: a large scale methodology to analyze the genetics expression profile of simultaneous samples in muscle, adipose tissue and lymphocytes obtained from the same individual].

Raúl A Bastarrachea1, Juan Carlos López-Alvarenga, Jack W Kent, Hugo A Laviada-Molina, Ricardo M Cerda-Flores, Ana Laura Calderón-Garcidueñas, Amada Torres-Salazar, Amanda Torres-Salazar, Edna J Nava-González, Elizabeth Solis-Pérez, Esther C Gallegos-Cabrales, Shelley A Cole, Anthony G Comuzzie.   

Abstract

OBJECTIVE: We describe the methodology used to analyze multiple transcripts using microarray techniques in simultaneous biopsies of muscle, adipose tissue and lymphocytes obtained from the same individual as part of the standard protocol of the Genetics of Metabolic Diseases in Mexico: GEMM Family Study.
METHODS: We recruited 4 healthy male subjects with BM1 20-41, who signed an informed consent letter. Subjects participated in a clinical examination that included anthropometric and body composition measurements, muscle biopsies (vastus lateralis) subcutaneous fat biopsies anda blood draw. All samples provided sufficient amplified RNA for microarray analysis. Total RNA was extracted from the biopsy samples and amplified for analysis.
RESULTS: Of the 48,687 transcript targets queried, 39.4% were detectable in a least one of the studied tissues. Leptin was not detectable in lymphocytes, weakly expressed in muscle, but overexpressed and highly correlated with BMI in subcutaneous fat. Another example was GLUT4, which was detectable only in muscle and not correlated with BMI. Expression level concordance was 0.7 (p< 0.001) for the three tissues studied.
CONCLUSIONS: We demonstrated the feasibility of carrying out simultaneous analysis of gene expression in multiple tissues, concordance of genetic expression in different tissues, and obtained confidence that this method corroborates the expected biological relationships among LEPand GLUT4. TheGEMM study will provide a broad and valuable overview on metabolic diseases, including obesity and type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19112718

Source DB:  PubMed          Journal:  Gac Med Mex        ISSN: 0016-3813            Impact factor:   0.302


  2 in total

1.  Integrating genomic analysis with the genetic basis of gene expression: preliminary evidence of the identification of causal genes for cardiovascular and metabolic traits related to nutrition in Mexicans.

Authors:  Raúl A Bastarrachea; Esther C Gallegos-Cabriales; Edna J Nava-González; Karin Haack; V Saroja Voruganti; Jac Charlesworth; Hugo A Laviada-Molina; Rosa A Veloz-Garza; Velia Margarita Cardenas-Villarreal; Salvador B Valdovinos-Chavez; Patricia Gomez-Aguilar; Guillermo Meléndez; Juan Carlos López-Alvarenga; Harald H H Göring; Shelley A Cole; John Blangero; Anthony G Comuzzie; Jack W Kent
Journal:  Adv Nutr       Date:  2012-07-01       Impact factor: 8.701

2.  Deep Multi-OMICs and Multi-Tissue Characterization in a Pre- and Postprandial State in Human Volunteers: The GEMM Family Study Research Design.

Authors:  Raul A Bastarrachea; Hugo A Laviada-Molina; Edna J Nava-Gonzalez; Irene Leal-Berumen; Claudia Escudero-Lourdes; Fabiola Escalante-Araiza; Vanessa-Giselle Peschard; Rosa A Veloz-Garza; Karin Haack; Angélica Martínez-Hernández; Francisco M Barajas-Olmos; Fernanda Molina-Segui; Fatima A Buenfil-Rello; Lucia Gonzalez-Ramirez; Reinhard Janssen-Aguilar; Ricardo Lopez-Muñoz; Fernanda Perez-Cetina; Janeth F Gaytan-Saucedo; Zoila Vaquera; Judith Cornejo-Barrera; Juan Carlos Castillo-Pineda; Areli Murillo-Ramirez; Sara P Diaz-Tena; Benigno Figueroa-Nuñez; Laura González-López; Rocío A Salinas-Osornio; Melesio E Valencia-Rendón; José Ángeles-Chimal; Jesús Santa-Olalla Tapia; José M Remes-Troche; Salvador B Valdovinos-Chavez; Eira E Huerta-Avila; Xianlin Han; Lorena Orozco; Ernesto Rodriguez-Ayala; Susan Weintraub; Esther C Gallegos-Cabrales; Shelley A Cole; Jack W Kent
Journal:  Genes (Basel)       Date:  2018-11-02       Impact factor: 4.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.